Reme-Flu
- Manufacturer
- Legacy Biotechnologies Inc. | Washington Homeopathic Products
- Effective date
- 2009-12-22
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-06-01 02:02:06
Label at a glance#
ProductReme-Flu
Active ingredientERIODICTYON, EUCALYPTUS GLOBULUS LEAF, INULA, SAMBUCUS NIGRA FLOWER, POTASSIUM CHLORIDE, SODIUM CHLORIDE, MAGNESIUM PHOSPHATE, TRIBASIC CALCIUM PHOSPHATE, BRYONIA ALBA ROOT, EUPATORIUM PERFOLIATUM FLOWERING TOP, ARSENIC, GELSEMIUM SEMPERVIRENS ROOT
Label structure13 sections
Contacts and useful links#
Websitewww.remeflu.com
www.remeflu.com
www.remeflu.comLabel contents#
Full prescribing information#
OTC - ACTIVE INGREDIENT SECTION
Active Ingredients Purpose
Part 2 Each 20 drop dose contains: Immunity Support
Eriodictyon californicum Greene 3X HPUS
Eucalptus globulus Labill 3X HPUS
Inula helenium L. 3X HPUS
Sambucus nigra L. 3X HPUS
Potassium Chloride 12X HPUS
Sodium Chloride 12X HPUS
Magnesium Phosphate dibasic 12X HPUS
Calcium Phosphate 12X HPUS
OTC - ACTIVE INGREDIENT SECTION
Active Ingredients Purpose
Part 1 Each pellet contains: Immunity Support
Bryonia alba L. 3X HPUS
Eupatorium perfoliatum L. 3X HPUS
Gelsemium sempervirens Ait. 3X HPUS
Arsenicum album 6X HPUS
Anas barbariae 200C HPUS
OTC - PURPOSE SECTION
Uses
For relief of symptoms of chills, body aches and pains, fever, runny nose and cough associated with the flu.
WARNINGS SECTION
Warnings
If pregnant or breastfeeding consult your health care practitioner before use
Keep out of reach of children. Do not use if blister pack is broken or if seal neck band on bottle is broken or missing.
If symptoms persist or recur or if new symptoms occur, discontinue use and consult your physician.
DOSAGE FORMS & STRENGTHS SECTION
Directions
For adults and children over 6 years of age.
Part 1 - Allow pellet to dissolve in mouth.
Take Part 1 and Part 2 three times per day, or as directed by your physician.
Do not eat or drink anything 15 minutes before or after taking.
Do not exceed 3 doses per day.
INACTIVE INGREDIENT SECTION
Inactive Ingredients
Part 1 Lactose, Sucrose
Part 2 Ethyl Alcohol, Purified Water
OTC - QUESTIONS SECTION
Questions or Comments
Call 866-577-6660, Or by email www.remeflu.com
DESCRIPTION SECTION
Legacy Biotechnologies, Inc.
Manufactured for:
Legacy Biotechnologies, Inc.
Distributed Exclusively By:
Legacy Biotechnologies, Inc.
334 East Lake Rd Number 187
Palm Harbor, FL 34685 866-577-6660
www.remeflu.comTamper Evident Statement: This package has
been sealed closed for your safety. Do not use this product if tamper evident
seal has been broken, tampered or is missing.
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
Reme-Flu
Homeopathic Medicine
Anas barbariae, Bryonia alba L.,
Eupatorium perfoliatum L., Gelsemium sempervirens Ait.,
and Arsenicum album in pellets
Natural Relief For Symptoms Of The Flu:
Body Aches and Pains
Cough
Fever and Chills
Runny Nose
12 Doses - 12 Pellets
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
Reme-Flu
Homeopathic Medicine
Eriodictyon californicum Greene, Eucalptus globulus Labill.,
Inula helenium L., Sambucus nigra L., Potassium Chloride,
Sodium Chloride, Magnesium Phosphate dibasic,
Calcium Phosphate in Liquid
Syn-X9
Natural Relief For Symptoms Of The Flu:
Body Aches and Pains
Cough
Fever and Chills
Runny Nose
12 Doses / 0.5 fl oz (15mL)
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 50107-100-00 | 2019-10-21 | C162847 | 48780-1 | 956f9ecf-bd4b-621f-e053-dbdaa90a74ad | Reme-Flu Homeopathic Medicine |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50107-100-00 | Reme-Flu | 1 in 1 KIT | KIT | 1 | 1 | |
| 50107-200-00 | Reme-Flu | 12 in 1 BOTTLE, DROPPER | LIQUID | 12 | 3 [hp_X] | 1 |
| 50107-300-00 | Reme-Flu | 12 in 1 BLISTER PACK | PELLET | 12 | 6 [hp_X] | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 50107-100 | REME-FLU (BRYONIA ALBA ROOT,EUPATORIUM PERFOLIATUM FLOWERING TOP,GELSEMIUM SEMPERVIRENS ROOT, ARSENIC, ERIODICTYON, EUCALYPTUS GLOBULUS LEAF , INULA, SAMBUCUS NIGRA FLOWER, POTASSIUM CHLORIDE, SODIUM CHLORIDE , MAGNESIUM PHOSPHATE , TRIBASIC CALCIUM PHOSPHATE ) KIT [LEGACY BIOTECHNOLOGIES INC.] | 1 | Legacy NDC, 3 package rows | 20091224_705f016c-4bdc-4a5c-8b38-324eee861cf2.zip |
| 50107-200 | REME-FLU (BRYONIA ALBA ROOT,EUPATORIUM PERFOLIATUM FLOWERING TOP,GELSEMIUM SEMPERVIRENS ROOT, ARSENIC, ERIODICTYON, EUCALYPTUS GLOBULUS LEAF , INULA, SAMBUCUS NIGRA FLOWER, POTASSIUM CHLORIDE, SODIUM CHLORIDE , MAGNESIUM PHOSPHATE , TRIBASIC CALCIUM PHOSPHATE ) KIT [LEGACY BIOTECHNOLOGIES INC.] | 1 | Unmatched | 20091224_705f016c-4bdc-4a5c-8b38-324eee861cf2.zip |
| 50107-300 | REME-FLU (BRYONIA ALBA ROOT,EUPATORIUM PERFOLIATUM FLOWERING TOP,GELSEMIUM SEMPERVIRENS ROOT, ARSENIC, ERIODICTYON, EUCALYPTUS GLOBULUS LEAF , INULA, SAMBUCUS NIGRA FLOWER, POTASSIUM CHLORIDE, SODIUM CHLORIDE , MAGNESIUM PHOSPHATE , TRIBASIC CALCIUM PHOSPHATE ) KIT [LEGACY BIOTECHNOLOGIES INC.] | 1 | Unmatched | 20091224_705f016c-4bdc-4a5c-8b38-324eee861cf2.zip |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| ARSENIC | ACTIVE INGREDIENT | N712M78A8G | 1 | |
| BRYONIA ALBA ROOT | ACTIVE INGREDIENT | T7J046YI2B | 1 | |
| ERIODICTYON | ACTIVE INGREDIENT | 2Y7TIQ135H | 1 | |
| EUCALYPTUS GLOBULUS LEAF | ACTIVE INGREDIENT | S546YLW6E6 | 1 | |
| EUPATORIUM PERFOLIATUM FLOWERING TOP | ACTIVE INGREDIENT | 1W0775VX6E | 1 | |
| GELSEMIUM SEMPERVIRENS ROOT | ACTIVE INGREDIENT | 639KR60Q1Q | 1 | |
| INULA | ACTIVE INGREDIENT | E55SMD6DA8 | 1 | |
| MAGNESIUM PHOSPHATE | ACTIVE INGREDIENT | 453COF7817 | 1 | |
| POTASSIUM CHLORIDE | ACTIVE INGREDIENT | 660YQ98I10 | 1 | |
| SAMBUCUS NIGRA FLOWER | ACTIVE INGREDIENT | 07V4DX094T | 1 | |
| SODIUM CHLORIDE | ACTIVE INGREDIENT | 451W47IQ8X | 1 | |
| TRIBASIC CALCIUM PHOSPHATE | ACTIVE INGREDIENT | 91D9GV0Z28 | 1 | |
| ARSENIC | ACTIVE MOIETY | N712M78A8G | 1 | |
| BRYONIA ALBA ROOT | ACTIVE MOIETY | T7J046YI2B | 1 | |
| CALCIUM CATION | ACTIVE MOIETY | 2M83C4R6ZB | 1 | |
| ERIODICTYON | ACTIVE MOIETY | 2Y7TIQ135H | 1 | |
| EUCALYPTUS GLOBULUS LEAF | ACTIVE MOIETY | S546YLW6E6 | 1 | |
| EUPATORIUM PERFOLIATUM FLOWERING TOP | ACTIVE MOIETY | 1W0775VX6E | 1 | |
| GELSEMIUM SEMPERVIRENS ROOT | ACTIVE MOIETY | 639KR60Q1Q | 1 | |
| INULA | ACTIVE MOIETY | E55SMD6DA8 | 1 | |
| MAGNESIUM CATION | ACTIVE MOIETY | T6V3LHY838 | 1 | |
| POTASSIUM CATION | ACTIVE MOIETY | 295O53K152 | 1 | |
| SAMBUCUS NIGRA FLOWER | ACTIVE MOIETY | 07V4DX094T | 1 | |
| SODIUM CATION | ACTIVE MOIETY | LYR4M0NH37 | 1 | |
| ALCOHOL | INACTIVE INGREDIENT | 3K9958V90M | 1 | |
| LACTOSE | INACTIVE INGREDIENT | J2B2A4N98G | 1 | |
| SUCROSE | INACTIVE INGREDIENT | C151H8M554 | 1 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 1 |
Products#
Every source-derived product name is available through these pages.
- Reme-Flu
- BRYONIA ALBA ROOT,EUPATORIUM PERFOLIATUM FLOWERING TOP,GELSEMIUM SEMPERVIRENS ROOT, ARSENIC, ERIODICTYON, EUCALYPTUS GLOBULUS LEAF , INULA, SAMBUCUS NIGRA FLOWER, POTASSIUM CHLORIDE, SODIUM CHLORIDE , MAGNESIUM PHOSPHATE , TRIBASIC CALCIUM PHOSPHATE
- Reme-Flu Homeopathic Medicine Syn-X9
- ERIODICTYON.EUCALYPTUS GLOBULUS LEAF, INULA,SAMBUCUS NIGRA FLOWER,POTASSIUM CHLORIDE,SODIUM CHLORIDE,MAGNESIUM PHOSPHATE,TRIBASIC CALCIUM PHOSPHATE
- ERIODICTYON
- EUCALYPTUS GLOBULUS LEAF
- INULA
- SAMBUCUS NIGRA FLOWER
- POTASSIUM CHLORIDE
- POTASSIUM CATION
- SODIUM CHLORIDE
- SODIUM CATION
- MAGNESIUM PHOSPHATE
- MAGNESIUM CATION
- TRIBASIC CALCIUM PHOSPHATE
- CALCIUM CATION
- ALCOHOL
- WATER
- Reme-Flu Homeopathic Medicine
- BRYONIA ALBA ROOT,EUPATORIUM PERFOLIATUM FLOWERING TOP, GELSEMIUM SEMPERVIRENS ROOT, ARSENIC
- BRYONIA ALBA ROOT
- EUPATORIUM PERFOLIATUM FLOWERING TOP
- ARSENIC
- GELSEMIUM SEMPERVIRENS ROOT
- LACTOSE
- SUCROSE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 50107-100 | 50107-100-00 |
| 50107-200 | 50107-200-00 |
| 50107-300 | 50107-300-00 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| ERIODICTYON | 2Y7TIQ135H | ACTIB |
| EUCALYPTUS GLOBULUS LEAF | S546YLW6E6 | ACTIB |
| INULA | E55SMD6DA8 | ACTIB |
| SAMBUCUS NIGRA FLOWER | 07V4DX094T | ACTIB |
| POTASSIUM CHLORIDE | 660YQ98I10 | ACTIB |
| SODIUM CHLORIDE | 451W47IQ8X | ACTIB |
| MAGNESIUM PHOSPHATE | 453COF7817 | ACTIB |
| TRIBASIC CALCIUM PHOSPHATE | 91D9GV0Z28 | ACTIB |
| ALCOHOL | 3K9958V90M | IACT |
| WATER | 059QF0KO0R | IACT |
| BRYONIA ALBA ROOT | T7J046YI2B | ACTIB |
| EUPATORIUM PERFOLIATUM FLOWERING TOP | 1W0775VX6E | ACTIB |
| ARSENIC | N712M78A8G | ACTIB |
| GELSEMIUM SEMPERVIRENS ROOT | 639KR60Q1Q | ACTIB |
| LACTOSE | J2B2A4N98G | IACT |
| SUCROSE | C151H8M554 | IACT |
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| SUCROSE | SUCROSE | C151H8M554 | TABLET, DELAYED RELEASE / ORAL | 295.33 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | INJECTION / INTRAVENOUS | 1950 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET, EFFERVESCENT / ORAL | 96.5 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SUSPENSION / RECTAL | 0.35 %v/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / ORAL | 6624 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | TROCHE / BUCCAL | NA | ||
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 620 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | PASTILLE / ORAL | 426 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | INJECTION, SOLUTION / INTRAVENOUS | 0.45 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION / INTRAVENOUS | 92 %w/v | ||
| LACTOSE | LACTOSE | J2B2A4N98G | INJECTION / INTRAMUSCULAR | 203.5 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL / NASAL | 20 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET, EXTENDED RELEASE / ORAL | 400 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, METERED / NASAL | 70 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL / TOPICAL | 561 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY / SUBLINGUAL | 397 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | DROPS / ORAL | NA | ||
| LACTOSE | LACTOSE | J2B2A4N98G | CONCENTRATE / ORAL | NA | ||
| SUCROSE | SUCROSE | C151H8M554 | INJECTABLE, LIPOSOMAL / INTRAVENOUS | 7560 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | LOZENGE / BUCCAL | NA | ||
| SUCROSE | SUCROSE | C151H8M554 | SOLUTION / ORAL | 70000 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / DENTAL | 12.8 %w/w | ||
| LACTOSE | LACTOSE | J2B2A4N98G | POWDER / RESPIRATORY (INHALATION) | 90 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | MOUTHWASH / BUCCAL | 200 mg/1ml | ||
| SUCROSE | SUCROSE | C151H8M554 | CONCENTRATE / ORAL | 4800 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | SUSPENSION, EXTENDED RELEASE / ORAL | 5400 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | CAPSULE, COATED, EXTENDED RELEASE / ORAL | NA | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LIQUID / INTRAVENOUS | 400 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET, SUGAR COATED / ORAL | NA | ||
| SUCROSE | SUCROSE | C151H8M554 | SOLUTION / RECTAL | 35.42 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | PASTE / DENTAL | 1.8 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CAPSULE, EXTENDED RELEASE / ORAL | 8 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | POWDER, FOR SUSPENSION / ORAL | 40017 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION, CONCENTRATE / ORAL | 150.68 mg/1ml | ||
| SUCROSE | SUCROSE | C151H8M554 | INJECTION, SUSPENSION, LIPOSOMAL / INTRAVENOUS | 9.4 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION / INTRAMUSCULAR | 1491 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, SPRAY / TOPICAL | 561 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 2000 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | POWDER / VAGINAL | 430 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET, DELAYED RELEASE / ORAL | 160 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | TABLET, CHEWABLE / ORAL | 7258 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL / RECTAL | 898 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | TABLET / BUCCAL | 109 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SHAMPOO / TOPICAL | 714 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SWAB / TOPICAL | 2250 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | GRANULE / ORAL | NA | ||
| SUCROSE | SUCROSE | C151H8M554 | POWDER / ORAL | 27768 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | OINTMENT / TOPICAL | NA | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / TRANSDERMAL | 49.37 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SYRUP / ORAL | 21000 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | POWDER, FOR SOLUTION / TOPICAL | 40 %w/w | ||
| SUCROSE | SUCROSE | C151H8M554 | CAPSULE, COATED, EXTENDED RELEASE / ORAL | 86 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | CAPSULE / ORAL | 3568 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | INJECTION, EMULSION / INTRAVENOUS | 970 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | CAPSULE / RESPIRATORY (INHALATION) | 44.4 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LIQUID / ORAL | 3563 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | SUSPENSION / ORAL | 48209 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | WAFER / ORAL | 155.2 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | TABLET, DELAYED RELEASE / ORAL | NA | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / INTRAVESICAL | 7892 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| dd6beeaf-c547-43cc-88e0-ffe9b64d9900 | 705f016c-4bdc-4a5c-8b38-324eee861cf2 | 2009-12-22 | Warnings | dd6beeaf-c547-43cc-88e0-ffe9b64d9900 705f016c-4bdc-4a5c-8b38-324eee861cf2 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.